Unique ID issued by UMIN | UMIN000014674 |
---|---|
Receipt number | R000017066 |
Scientific Title | ADPKD cohort study |
Date of disclosure of the study information | 2014/07/28 |
Last modified on | 2023/04/11 10:27:52 |
ADPKD cohort study
ADPKD cohort study
ADPKD cohort study
ADPKD cohort study
Japan |
autosomal dominant polycystic kidney disease(ADPKD)
Nephrology |
Others
YES
We investigate the increase speed of the kidney capacity of the autosomal dominant polycystic kidney disease (ADPKD) patient and renal function aggravation speed. In addition, We examine the frequency of complications in ADPKD and prevalence in Ibaraki.
Others
1)Epidemiology investigation and complications in ADPKD
2)Influence of quality of life (QOL) and the hypoxemia
3)Effect of tolvaptan
Exploratory
Not applicable
the increase of kidney volume
(1) Aggravation speed of renal function (eGFR or the inulin clearance
(2) Death
(the cause of death:) Infectious disease, malignant tumor, cardiovascular disease, cerebropathy, liver failure, respiratory failure, sudden death, other (accident, fall) ignorance)
(3) Kidney composition endpoint (more than 25% drop of dialysis introduction, renal transplantation, 1/sCr or eGFR, renal artery embolus therapy)
(4) Cardiovascular event (cerebral hemorrhage, subarachnoid hemorrhage, cerebral infarction, myocardial infarction, angina, heart failure, peripheral artery stenosis to need hospitalization)
(5) Infectious disease (cyst infection, large intestine diverticulitis) to need hospitalization
(6) Cyst bleeding to need hospitalization
(7) Serious liver damage
(an ascent more than the twice the standard value upper limit of total bilirubin and a rise more than 3 times of the standard value upper limit in serum ALT or AST)
(8) Kidney plasma flow quantity
(9) Prevalence
(10) Gene variation
Observational
Not applicable |
Not applicable |
Male and Female
ADPKD
The patient who study responsibility doctor or study allotment doctor judged inappropriate patient.
The patient who was not agreed informed consent.
200
1st name | Kunihiro |
Middle name | |
Last name | Yamagata |
university of tsukuba,faculty of medicine
department of nephrology
305-8575
1-1-1,Tennodai,Tsukuba,Ibaraki, Japan
029-853-3202
k-yamaga@md.tsukuba.ac.jp
1st name | Hirayasu |
Middle name | |
Last name | Kai |
university of tsukuba,faculty of medicine
department of nephrology
3058575
1-1-1,Tennodai,Tsukuba,Ibaraki, Japan
029-853-3202
hirayasu.kai@md.tsukuba.ac.jp
university of tsukuba,faculty of medicine,department of nephrology
university of tsukuba,faculty of medicine,department of nephrology,Money of authorized accounting
Other
Tsukuba Clinical Research & Development Organization
Tsukuba city, Amakubo, 2-1-1
0298533914
rinshokenkyu@un.tsukuba.ac.jp
NO
2014 | Year | 07 | Month | 28 | Day |
Unpublished
No longer recruiting
2014 | Year | 06 | Month | 13 | Day |
2014 | Year | 06 | Month | 14 | Day |
2014 | Year | 06 | Month | 14 | Day |
2023 | Year | 03 | Month | 31 | Day |
200 patients in ADPKD would be enrolled.
A registration period: From an Ethical Review Board approval day to March 31, 2020.
2014 | Year | 07 | Month | 28 | Day |
2023 | Year | 04 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017066
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |